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West Nile virus (WNV) is the most common
arthropod-borne flavivirus in the United States;
however, the vector ligand(s) that participate in infec-
tion are not known. We now show that an Aedes
aegypti C-type lectin, mosGCTL-1, is induced by
WNV, interacts with WNV in a calcium-dependent
manner, and facilitates infection in vivo and in vitro.
A mosquito homolog of human CD45 in A. aegypti,
designated mosPTP-1, recruits mosGCTL-1 to
enable viral attachment to cells and to enhance viral
entry. In vivo experiments show thatmosGCTL-1 and
mosPTP-1 function as part of the same pathway
and are critical for WNV infection of mosquitoes.
A similar phenomenon was also observed in Culex
quinquefasciatus, a natural vector of WNV, further
demonstrating that these genes participate in WNV
infection. During the mosquito blood-feeding pro-
cess, WNV infection was blocked in vivo with
mosGCTL-1 antibodies. A molecular understanding
of flaviviral-arthropod interactions may lead to strat-
egies to control viral dissemination in nature.
INTRODUCTION
West Nile virus (WNV) is maintained in a bird-mosquito transmis-
sion cycle and has become the most common arthropod-borne
flavivirus in the United States. Humans, horses, and other nona-
vian vertebrates are incidental hosts (Monath and Heinz, 1996).
Infection in man can result in fever, meningitis, or encephalitis,
among other symptoms (Huba´lek and Halouzka, 1999; Leis
et al., 2002). Approved human vaccines or therapeutics are not
available and preventive measures largely focus upon mosquito
control (Reisen and Brault, 2007).
The ability of different mosquito species to transmit WNV
varies widely. Culex spp. are the major vectors for WNV world-714 Cell 142, 714–725, September 3, 2010 ª2010 Elsevier Inc.wide (Nir et al., 1968; Turell et al., 2000). In the United States,
the most important vectors are Culex pipiens in the east, Culex
tarsalis in the midwest and west, and Culex quinquefasciatus in
the southeast (Hayes et al., 2005). WNV has also been isolated
from Aedes, Ochlerotatus, and Culisetam mosquitoes (http://
www.cdc.gov/ncidod/dvbid/westnile/mosquitoSpecies.htm).
Aedes aegypti, a member of the Culicinae subfamily, is a major
vector for numerous flaviviruses (Gould and Solomon, 2008).
A. aegypti is ideal for viral pathogenesis studies because these
mosquitoes are easy to cultivate and the genome has been char-
acterized (Gubler, 1998; Nene et al., 2007; Halstead, 2008).
A. aegypti is readily susceptibility to infection with WNV in
the laboratory, and the virus rapidly disseminates throughout
most of the mosquito after the blood meal. As with Culex spp.,
A. aegypti is a threat for the transmission of WNV to humans
(Vanlandingham et al., 2007).
C-type lectins are a group of carbohydrate-binding proteins
(Zelensky and Gready, 2005). Several members of this family
are highly expressed by immune cells, including monocytes,
macrophages, and dendritic cells (DCs), and play a central
role in activating host defenses (Robinson et al., 2006). Human
mannose-binding lectin (MBL) is a pattern recognition molecule
of the innate immune system that binds to sugars on the surface
of invading pathogens, leading to opsonization, phagocytosis,
and activation of the complement pathway (Neth et al., 2002).
In contrast, some C-type lectins are recruited to facilitate flavivi-
ral infection. In mammals, two membrane C-type lectins,
DC-SIGN (CD209) and L-SIGN (CD209L), interact with flavivi-
ruses via high mannose glycans on viral glycoproteins (Klimstra
et al., 2003) and are essential host cell factors exploited by
dengue virus (DENV) and WNV to invade immature DCs and
macrophages (Geijtenbeek et al., 2000; Soilleux et al., 2002;
Tassaneetrithep et al., 2003; Davis et al., 2006). Another
C-type lectin, the mannose receptor (MR), also interacts with
the DENV envelope protein and may enhance viral attachment
to phagocytes (Miller et al., 2008). A recent study identified
C-type lectin domain family 5, member A (CLEC5A), as
a DENV receptor. The association between CLEC5A and
DENV does not result in viral entry, but rather stimulates the
Figure 1. Effect of WNV Infection on mosGCTL-1 Expression
(A) Viral distribution in A. aegypti. WNV (1 3 103 M.I.D50) was inoculated into the mosquito thorax.
(B–E)mosGCTL-1messenger RNA (mRNA) was induced by viral infection in whole A. aegypti (B), salivary glands (C), hemolymph (D), and midgut (E). Total RNA
was isolated from various tissues or whole mosquitoes at 5 time points after viral infection.
(A–E) The viral load and mosGCTL-1 mRNA levels were determined by Taqman RT-QPCR and normalized with A. aegypti actin (AAEL011197). WNV (1 3 103
M.I.D50) was microinjected into each mosquito. Data are shown as the mean ± standard error (SEM). The experiments were repeated three times.
(F) Immunoblot to detect mosGCTL-1 in WNV-infected mosquitoes. Three WNV infected or control mosquitoes were pooled and homogenized. The supernatant
was then isolated, separated by SDS-PAGE, and probed with rabbit mosGCTL-1 antisera. UI, uninfected mosquitoes; I, WNV-infected mosquitoes; dpi, days
postinfection. Fifty micrograms of protein from mosquito lysates was loaded into each lane.
See also Figure S1 and Table S1.release of proinflammatory cytokines, potentially contributing to
the pathogenesis of dengue hemorrhagic fever (Chen et al.,
2008).
Protein tyrosine phosphatases (PTPs) remove phosphate
groups from phosphorylated tyrosine residues and play critical
roles in cell communication, shape, motility, proliferation, and
differentiation (Alonso et al., 2004; Mustelin et al., 2005). Onewell-known PTP, protein tyrosine phosphatase receptor type C
(PTPRC, CD45), is important for thymocyte development and
T cell activation (Byth et al., 1996; Trowbridge and Thomas,
1994) and is expressed on all nucleated cells of hemopoietic
origin (Thomas, 1989). The association between MBL and
CD45 in immature T cells influences thymocyte development
(Baldwin and Ostergaard, 2001).Cell 142, 714–725, September 3, 2010 ª2010 Elsevier Inc. 715
Figure 2. The Function of mosGCTL-1 in WNV Infection
(A and B)mosGCTL-1 silencing. Themock group was treated with the same amount ofGFP dsRNA.mosGCTL-1- orGFP-dsRNA-treated mosquitoes were used
to isolate total RNA at several time points post dsRNA injection. mRNA levels were determined by SYBR Green RT-QPCR (A). mosGCTL-1-dsRNA-treated or
mock-treated mosquitoes were collected at 6 days after gene silencing. The supernatant was separated by SDS-PAGE and probed with rabbit mosGCTL-1
antisera (B).
(C and D) SilencingmosGCTL-1 impairs WNV (C), but not dengue virus (D), infection. The viral burden was examined at day 6 after infection. WNV or dengue virus
(10 M.I.D50) was used to challenge mosquitoes. The viral load was determined by Taqman RT-QPCR and normalized with A. aegypti actin. The result shown was
representative of four independent experiments.
(E) The role of themosGCTL paralogues inWNV infection. The sample number was no less than 12mosquitoes in each group. The viral burdenwas determined by
Taqman RT-QPCR and normalized with A. aegypti actin. *p < 0.05. The results were pooled from two independent experiments.
(F) WNV induces mosGCTL-1 homolog expression in C. quinquefasciatus. WNV-infected and mock mosquitoes were collected at 6 days after infection. Culex
mosGCTL-1mRNAwas determined by SYBRGreen RT-QPCR and normalized withC. quinquefasciatus actin (CPIJ012570). The experiment was repeated three
times with similar results.
(G) Efficiency ofCulexmosGCTL-1RNA interference. Themock groupwas treatedwith the same amount ofGFP dsRNA.mRNA levels were determined by SYBR
Green RT-QPCR.
(H) Silencing of Culex mosGCTL-1 decreases the WNV burden in C. quinquefasciatus. The viral burden was determined by Taqman RT-QPCR. The results were
combined from three independent experiments.
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Genome-wide RNA interference (RNAi) screening studies
have revealed several hundred host factors that influence WNV
or DENV infection in human or Drosophila cell lines and have
identified cellular pathways that have a role in viral internaliza-
tion, replication, assembly, or secretion (Krishnan et al., 2008;
Sessions et al., 2009). However, the relationship between flavivi-
ruses and mosquitoes is not well understood. We now examine
WNV-mosquito interactions by using A. aegypti and Culex quin-
quefasciatus, characterize the expression profile of mosquito
homologs of human susceptibility proteins (Krishnan et al.,
2008) in response to viral infection, and identify a lectin-based
pathway that is critical for viral infection of mosquitoes.RESULTS
A recent RNAi screening study characterized 283 human
proteins that facilitate WNV infection (Krishnan et al., 2008).
We have now identified 215 homologs of these genes in
A. aegypti. The expression of 32 genes was altered by the pres-
ence of WNV in mosquitoes, potentially suggesting a role in viral
infection of the arthropod (Table S1 available online). To examine
their function, we therefore silenced each of these 32 genes in
mosquitoes with RNAi and assessed the effect on viral load.
Knockdown of 13 genes significantly altered the viral burden in
the vector (Table S1 and Figure S1). One of these genes,
AAEL000563, exhibited the most dramatic reduction in viral
load after silencing and was selected as the target for further
investigation. AAEL000563 belongs to the A. aegypti galac-
tose-specific binding C-type lectin family, shares 26% amino
acid identity with human mannose-binding lectin, and was
designated asmosGCTL-1 (mosquito galactose-specific binding
C-type lectin).mosGCTL-1 Expression Increases during WNV Infection
of A. aegypti
To further investigate the relationship between WNV infection
and mosGCTL-1 expression, we determined the viral load and
mosGCTL-1 level in selected A. aegypti tissues after the inocula-
tion of WNV into female mosquitoes. WNV was readily detect-
able 4 days after infection, and the viral level subsequently
increased. The salivary glands and hemolymph had the highest
levels of WNV, while the viral load in themidgut was substantially
lower (Figure 1A). mosGCTL-1 expression was induced in
diverse tissues over time, including the salivary glands, hemo-
lymph, and midgut (Figures 1B–1E). Immunoblots also demon-
strated an increased amount of mosGCTL-1 in WNV-infected
mosquitoes (Figure 1F).mosGCTL-1 Facilitates WNV Infection in A. aegypti
Double-stranded RNA (dsRNA)-mediated gene silencing studies
then assessed the role of mosGCTL-1 in WNV infection of(A, C, D and H) Statistical analysis was done with the Mann-Whitney test in all e
The horizontal line depicts the medians.
(E–G) The Mann-Whitney test was used for statistical analysis. Data are shown a
See also Figure S2 and Table S2.mosquitoes. Total RNA from mock-injected and mosGCTL-1
dsRNA-injected mosquitoes was analyzed by RT-QPCR. Com-
pared to the mock group, the target gene was silenced 6- to
10-fold from day 3 through 9 (Figures 2A and 2B). WNV was
therefore inoculated intomosquitoes on day 3 after dsRNA treat-
ment, and the viral load was quantified on day 9. There was
a 3-fold reduction in the WNV burden in mosGCTL-1 silenced
A. aegypti (Figure 2C, p < 0.0001) compared to controls.
In contrast, the burden of a related flavivirus, dengue virus,
was unaffected bymosGCTL-1 silencing (Figure 2D), suggesting
that mosGCTL-1 has a specific role in WNV infection of
mosquitoes.
As mosGCTL-1 is part of a multigene family with 25 members
and shares 22%–48% identity with many of these genes, we
examined the role of the mosGCTL paralogues in WNV and
DENV infection. Twenty-one of these 25 genes were expressed
in adult femaleA. aegypti (Tables S1 and S2). SinceAAEL014382
and AAEL014390 share greater than 95% identity with
AAEL011607 and AAEL011619, respectively, AAEL011607 and
AAEL011619 were selected for functional assays. We silenced
each of the expressed mosGCTL genes and then infected the
mosquitoes with virus. In the WNV challenge, two additional
mosGCTL subtypes (AAEL000556 and AAEL011610) showed
the similar phenotype to mosGCTL-1 (Figure 2E), and in DENV
infection, silencing of 5 mosGCTL-related genes reduced the
DENV burden (Figure S2).
Culex mosquitoes are a common vector for WNV in nature.
We therefore extended the studies to Culex quinquefasciatus,
a example of this species that is abundant in the southeast
U.S. We identified a mosGCTL-1 homolog (CPIJ010995, Culex
mosGCTL-1) in C. quinquefasciatus that has a higher degree
of similarity (64%) with mosGCTL-1 than other homologs.
We then determined whether Culex mosGCTL-1 had a similar
role in WNV infection. Culex mosGCTL-1 was upregulated by
WNV infection (Figure 2F). Silencing of Culex mosGCTL-1 in
C. quinquefasciatus reduced the WNV burden compared to the
control group (Figures 2G and 2H, p < 0.0001), suggesting that
Culex mosGCTL-1 plays a role in facilitating WNV infection in
Culex mosquitoes.mosGCTL-1 Interacts with WNV
Our results show that silencing mosGCTL-1 in A. aegypti and
C. quinquefasciatus reduces WNV infection. The mechanism
by which mosGCTL-1 facilitates viral infection in mosquitoes
was, therefore, investigated. We first generated A. aegypti
mosGCTL-1 protein in a Drosophila expression system (Fig-
ure 3A) and investigated whether mosGCTL-1 associates with
WNV envelope (E) protein. Immunoprecipitation experiments
revealed that these two proteins strongly interacted in a
calcium-dependent manner (Figure 3B). We then determined,
by ELISA, that mosGCTL-1 bound to WNV virions. mosGCTL-1xperiments. Each dot represents the mRNA levels in an individual mosquito.
s the mean ± standard error (SEM).
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Figure 3. mosGCTL-1 Interacts with WNV
(A) Recombinant mosGCTL-1, produced in Drosophila cells, and purified with a Ni-His column (left). Glycosylated mosGCTL-1 was detected with a V5-HRPmAb
(right). The control was the supernatant of mock-infected S2 cells.
(B) mosGCTL-1 interacted with WNV E protein in a coimmunoprecipitation assay. The protein complex was pulled down with a flavivirus E mAb and probed with
anti-V5-HRP mAb. The experiments were repeated three times.
(C) mosGCTL-1 captured West Nile virions by ELISA. The interaction was determined with a flavivirus E mAb. Data are expressed as the mean ± standard error
from three independent experiments.
(D) Comicroinjection of the purified mosGCTL-1 withWNV enhanced virus infection in A. aegypti. The various amount of purified mosGCTL-1 were premixed with
WNV (10M.I.D50 per mosquito) for 1 hr at 4
C. Themixture wasmicroinjected into mosquito and compared to the control group inoculated with the same amount
WNV. The mosquitoes were collected at 3 days (i), 6 days (ii), and 9 days (iii) after WNV inoculation. Total RNA was isolated to determine the viral burden by
Taqman RT-QPCR and normalized with A. aegypti actin. Each dot represents the mRNA level in one mosquito. The horizontal line represents the medians.
n.s., nonsignificance (p > 0.05). The Mann-Whitney test was used for analysis. Three independent experiments yielded similar data.
(E) The association between mosGCTL-1 and WNV in A .aegypti hemolymph. Hemolymph was collected from WNV-infected or mock-infected mosquitoes
for immunofluorescence staining. WNV E protein was stained with anti-mouse IgG Alexa-488 (green), and mosGCTL-1 was identified with anti-rabbit
IgG Alexa-546 (red). Nuclei were stained blue with To-Pro-3 iodide. The white arrow represents the induced expression of mosGCTL-1 in WNV-infected
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efficiently captured virus in the presence of calcium, and
this interaction was inhibited by EDTA (Figure 3C). Since this
association suggests a role during infection, we premixed
mosGCTL-1 and WNV and then coinjected the combination
into A. aegypti and determined the viral burden. mosGCTL-1
protein significantly enhanced the viral load at days 3 (Fig-
ure 3D, i, p = 0.0001) and 6 (Figure 3D, ii, p < 0.0001) after viral
challenge.
To further characterize the association between mosGCTL-1
and WNV infection in vivo, we used immunofluorescence to
examine the hemolymph and salivary glands of WNV-infected
A. aegypti at different time points. Colocalization of mosGCTL-1
and WNV was clearly observed in both tissues at various inter-
vals after WNV infection (Figure 3E and Figure S3). In the hemo-
lymph, some hemocytes were highly infected by WNV, and
mosGCTL-1 was induced in these infected hemocytes
(Figure 3E). We counted the number of mosGCTL-1-positive
and WNV-infected hemocytes by microscopy. All these infected
cells stained positive for mosGCTL-1. The virus spread rapidly to
the salivary glands after inoculation (Figure S3), consistent with
the Q-PCR data (Figure 1A). mosGCTL-1 was identified on the
basement membrane of salivary glands in uninfected mosqui-
toes, and throughout this tissue after infection, suggesting that
mosGCTL-1 was induced by WNV infection of the salivary
glands (Figure S3).
mosPTP-1 Captures mosGCTL-1 onto the Cell Surface
Human mannose-binding lectin (MBL) (Zelensky and Gready,
2005) and mosGCTL-1 are both secreted. Human MBL is
thought to interact with several surface receptors to exert pleo-
trophic effects (Baldwin and Ostergaard, 2001; Arnold et al.,
2006). We therefore postulated that secreted mosGCTL-1
captures WNV and presents it to a ligand on the cell surface,
thereby facilitating viral entry. To assess this, we identified 11
A. aegypti homologs of human proteins that putatively interact
with human MBL (Table S3) from the Human Protein Reference
Database (http://www.hprd.org/) and examined their roles in
WNV infection of A. aegypti (Figure S4A). One mosquito CD45
homolog (AAEL013105, mosPTP-1) exhibited a phenotype
similar to that of mosGCTL-1. The viral burden was significantly
decreased in the mosPTP-1 dsRNA-treated mosquitoes (p <
0.002) (Figures 4A and 4B). To further determine whether
mosPTP-1 interacts with mosGCTL-1, we cloned and expressed
the extracellular region of mosPTP-1 (mosPTP-1-Ex) in a
Drosophila cell line (Figure 4C). mosGCTL-1 strongly interacted
withmosPTP-1-Ex in a coimmunoprecipitation assay (Figure 4D).
We then expressed the mosPTP-1 gene, including the trans-
membrane region (91 bp–2202 bp), in S2 cells (Figure 4C) and
examined the ability of mosPTP-1 to bind mosGCTL-1 on the
cell surface. A mock DNA vector transfected stable S2 cell line
was used as control. More than 40% of the mosPTP-1-express-
ing cells bound mosGCTL-1 and showed double-positive stain-
ing in FACS (Figure 4E, i) compared with controls (Figure 4E, ii,
iii). Confocal microscopy demonstrated that cells expressinghemocytes. The yellow arrows show the infected hemocytes. Images were e
lens.
See also Figure S3.high levels of mosPTP-1 in the cytoplasm also had substantial
mosGCTL-1 on the cell surface (Figure 4F). These results
suggest that mosGCTL-1 binds mosPTP-1.
To test whethermosPTP-1 has a conserved role in Culex spp.,
we identified themosPTP-1 homolog from theCulex quinquefas-
ciatus genome (CPIJ014098, Culex mosPTP-1). Silencing of this
gene in Culex also influenced the viral burden (Figures S4B and
S4C), similar to mosPTP-1 in A. aegypti (Figure 4B), suggesting
that mosPTP-1 in both these mosquito species have a similar
role in WNV infection.
The mosGCTL-1/mosPTP-1 Pathway Has a Dominant
Role in WNV Infection
mosGCTL-1 and mosPTP-1 each facilitate WNV infection of
A. aegypti in vivo and in vitro. We therefore assessed whether
mosGCTL-1 and mosPTP-1 cooperate to enable viral infection.
WNV E protein, mosGCTL-1, and mosPTP-1-Ex form a complex
in which mosGCTL-1 is the key factor linking the other two
proteins (Figure 5A). WNV E protein did not interact directly
with mosPTP-1-Ex (Figure 5A). We then examined whether
mosPTP-1-expressing cells could recruit more WNV in the pres-
ence of mosGCTL-1. mosGCTL-1 and WNV were added to cells
and incubated at 4C for membrane attachment. After washing,
the cells were transferred to room temperature and collected at
different time points to determine the viral burden (Krishnan
et al., 2007). mosPTP-1-expressing cells incorporated up to
5- to 10-fold more WNV in the presence of mosGCTL-1, com-
pared to control groups (Figure 5B). We then examined the role
of the mosGCTL-1/mosPTP-1 pathway for WNV infection in
A. aegypti. We knocked down the mosPTP-1 gene with dsRNA
and then inoculated the mosGCTL-1/WNV mixture at 3 days
after RNAi silencing. Silencing of mosPTP-1 interfered with the
ability of mosGCTL-1 to facilitate WNV infection (shown in Fig-
ure 3D) at 3 and 6 days after challenge (Figure 5C). The viral
burden of the mosPTP-1 RNAi/mosGCTL-1/WNV group was
2- to 3-fold lower than that of the mock/mosGCTL-1/WNV group
(p < 0.001) and decreased to a level similar to that of the group
that did not receive mosGCTL-1, suggesting that mosGCTL-1
and mosPTP-1 cooperate in the same pathway to enhance
WNV infection. To further determine the relationship between
mosGCTL-1 and mosPTP-1 in infection, we silenced both of
these genes with dsRNA. These genes were successfully
knocked down in mosquitoes in the cosilenced group (Figures
S5A and S5B). The decrease in the viral burden was similar in
the cosilenced and individually silenced groups (Figure S5C),
suggesting that mosPTP-1 is the dominant downstream
receptor for mosGCTL-1 in the process of WNV infection of
A. aegypti.
To better understand the association between mosGCTL-1,
mosPTP-1, and WNV in vivo, we examined the distribution of
mosPTP-1 in A. aegypti. mosPTP-1 was highly expressed in
various mosquito tissues but not induced by WNV infection
(Figure S4D). The salivary glands and hemolymph were sites of
abundant mosPTP-1 expression, while expression in midgutxamined with a Zeiss LSM 510 Meta Confocal Microscope 633 objective
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Figure 4. mosPTP-1 Captures mosGCTL-1 onto the Cell Surface
(A) RNAi efficiency for the mosPTP-1 gene at 6 days after dsRNA treatment. The amount of mosPTP-1 mRNA was determined by SYBR Green RT-QPCR and
normalized with A. aegypti actin. Data are represented as the mean ± standard error.
(B) SilencingmosPTP-1 decreasedWNV infection. The viral burden wasmeasured at day 6.WNV (10M.I.D50) was injected into eachmosquito. The viral load was
determined by Taqman RT-QPCR and normalized with A. aegypti actin. Statistical analysis was done with the Mann-Whitney test. The horizontal line depicts the
medians. The result shown is a combination of three independent experiments.
(C) Expression of recombinant mosPTP-1 and mosPTP-1-Ex in S2 cells. mosPTP-1 and mosPTP-1-Ex genes were isolated from complementary DNA (cDNA)
library of A. aegypti and expressed as recombinant proteins with an HA tag at the N terminus. The left panel is mosPTP-1, and the right panel is mosPTP-1-EX,
probed by anti-HA tag mAb in western blot. The control was the products from S2 cells transfected with mock DNA vector.
(D) mosGCTL-1 interacts withmosPTP-1-Ex peptide by coimmunoprecipitation. The protein complex was pulled downwith a rabbit HA antibody and probedwith
a V5-HRP mAb. The experiments were repeated three times.
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was comparatively lower (Figures S4E–S4G). We next generated
mosPTP-1 antibody in mice, which recognized native mosPTP-1
protein (Figure S5D) and the mosPTP-1-Ex expressed by S2
cells (Figure S5E). We then determined the relationship between
mosGCTL-1, mosPTP-1, and WNV in salivary glands by immu-
nofluorescence. mosPTP-1 was copiously expressed on the
cell surface of salivary glands (Figure 5D), thereby providing
additional data to complement and extend the initial QPCR
expression data (Figure S4E). Several regions in the salivary
glands with substantial mosPTP-1 also demonstrated staining
for mosGCTL-1 and WNV (Figure 5D).
mosGCTL-1 Antisera Interferes with WNV Infection
of Mosquitoes
Disruption of the transfer of WNV from the vertebrate to
arthropod host could theoretically diminish viral dissemination
in nature. We therefore investigated whether mosGCTL-1 anti-
sera reduces WNV infection in mosquitoes during the blood
meal. We generated mosGCTL-1 antisera in rabbits and showed
that mosGCTL-1 antisera interfered with mosGCTL-1 binding to
WNV E protein in vitro (Figure 6A). Then, we examined whether
mosGCTL-1 antisera influenced the ability of WNV to infect
mosquitoes during a bloodmeal.WemixedmosGCTL-1 antisera
and WNV with fresh whole blood and performed membrane
blood feeding with a Hemotek. Seven days later, mosquitoes
were sacrificed to determine the infectivity rate. mosGCTL-1
antisera efficiently blocked WNV infection of A. aegypti. The
number of infected mosquitoes was reduced in mosGCTL-1
antisera treated groups, compared to mock group, by QPCR
(Figure 6B) or a 50% tissue culture infective doses (TCID50) assay
(Figure 6C). Hence, a humoral response against mosGCTL-1 in
a vertebrate host may alter WNV infection of mosquitoes during
the feeding process. This hypothetically affords a strategy to
develop a transmission blocking vaccine to control WNV
dissemination in nature.
DISCUSSION
As mosquitoes are prominent vectors for flaviviruses, specific
interactions between the virus and arthropod likely enhance
pathogen survival. In the mammalian host, C-type lectins such
as DC-SIGN and the mannose receptor augment viral entry
into specific DCs and macrophages (Tassaneetrithep et al.,
2003; Davis et al., 2006; Miller et al., 2008). Our results show
that a secreted mosquito C-type lectin, mosGCTL-1, binds to
WNV in a calcium-dependent manner and enhances viral infec-
tion. A mosquito homolog of human CD45 (mosPTP-1) recruits
mosGCTL-1 to facilitate viral attachment to cells. Based on our
findings, we envision a model whereby WNV that is inoculated(E) mosPTP-1 captured mosGCTL-1 to the cell surface by flow cytometry. A s
mosGCTL-1 was inoculated with mosPTP-1-expressing cells at 4C. An empty DN
between mosPTP-1 and mosGCTL-1 was investigated by FACS. mosPTP-1 was
independent experiments yielded similar results, and one representative study is
(F) Confocal microscopy to examine for mosPTP-1 and mosGCTL-1. mosGCTL-1
546 (red). Nuclei were stained by To-Pro-3 iodide (blue). The images were colle
The arrows represent the overlap between mosPTP-1 and mosGCTL-1.
See also Figure S4 and Table S3.into mosquitoes binds to secreted mosGCTL-1 in the hemo-
lymph, thereby forming a complex in the extracellular milieu
that has the ability to interact with the membrane protein,
mosPTP-1, to facilitate cellular entry. The virus rapidly replicates
in the mosquito thorax. This induces additional mosGCTL-1
expression, which accelerates formation of the mosGCTL-1/
WNV complex—enabling WNV to invade different mosquito
tissues and enhancing viral spread throughout the mosquito
body. This mechanism, which involves WNV associating with
mosGCTL-1 and then being captured by mosPTP-1 onto the
cell surface in mosquitoes, suggests that an extracellular soluble
protein is an important receptor for flavivirus in arthropods.
mosGCTL-1 shares homology with humanMBL. In mammals,
MBL is a pattern recognition molecule that recognizes carbohy-
dratemoieties on invadingmicrobes (Neth et al., 2002). As exam-
ples, MBL interacts with HIV envelope protein (gp120) (Saifuddin
et al., 2000) andHBVsurface antigen (HBsAg) (Chong et al., 2005)
and has a role in the opsonization of HIV (Ezekowitz et al., 1989).
In these processes, MBL associates with serine proteases,
MASPs, and activates the complement system (Neth et al.,
2002). Homologs of the proteins that associate with mammalian
MBLhavenot been found inA. aegypti (TableS3), suggesting that
theA. aegyptimosGCTL-1mayhavedifferent physiological func-
tions than mammalian MBL. Invertebrates lack antibody- and
interferon-based immune responses (Cheng et al., 2009). Since
lectin expression is significantly upregulated by microbial infec-
tion, these molecules are presumed to participate in nonself
recognition and pathogen resistance (Wilson et al., 1999; Tanji
et al., 2006). Indeed, recent studies have shown that a comple-
ment-like systemexists in the hemolymph ofAnopheles gambiae
and mediates parasite killing (Blandin et al., 2004; Povelones
et al., 2009). It is possible that mosGCTL-1 and other subtypes
in this family, similar to their mammalian homologs, may normally
recognize most pathogens and be involved in the arthropod
complement-like system. Nevertheless, our studies showed
that the expression of mosGCTL-1 is induced by WNV infection.
The inducedmosGCTL-1 that then binds to virus amplifies WNV
infection. Overall, these suggest a critical role formosGCTL-1 in
WNV infection of mosquitoes.
In the mammalian host, the association between MBL and the
CD45 external domain primarily occurs in immature T cells and
affect the development of thymocytes (Baldwin and Ostergaard,
2001). Mammalian CD45 is expressed on the hemopoietic-orig-
inated nucleated cells (Thomas, 1989); however, the mosquito
CD45 homolog, mosPTP-1, does not appear to be restricted to
particular cells. As a transmembrane protein, mosPTP-1 was
abundantly detected in the salivary glands and hemolymph of
mosquitoes. The pattern of mosPTP-1 expression correlated
with the distribution of WNV in A. aegypti. In our model, aftertable cell line was generated to express mosPTP-1 in S2 cells. The purified
A vector transfected stable S2 cell line was used as the control. The interaction
stained by Alexa-488; mosGCTL-1 was stained by Phycoerythrin (PE). Three
shown in this figure.
was stained with Alexa-488 (green) and mosPTP-1 was identified with Alexa-
cted using a Zeiss LSM 510 Meta Confocal Microscope 633 objective lens.
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Figure 5. The mosGCTL-1/mosPTP-1 Pathway in WNV Infection
(A) mosGCTL-1 associated withWNV E protein bound tomosPTP-1-Ex. The protein complex was pulled down with an HA antibody and probed with V5-HRP and
flavivirus E protein antibody. The experiment was repeated three times.
(B) mosPTP-1-expressing cells recruit WN virions in the presence of mosGCTL-1. mosGCTL-1 and WNV were added to cells and incubated at 4C for 1 hr, for
membrane attachment. Cells were gently washed three times with cold PBS and were then moved to room temperature. At different time points—0, 15, and
60 min—cells were collected for total RNA isolation. Control cells were the empty DNA vector transfected stable S2 cell line. Viral attachment was determined
by SYBR Green RT-QPCR and normalized with Drosophila actin 5C (CG4027). Statistical analysis was done with ANOVA. Data are represented as the mean ±
standard error. The results are representative of three independent experiments.
(C) Silencing of mosPTP-1 impairs the function of mosGCTL-1. The mosPTP-1 gene was knocked down with dsRNA treatment. Then the mosGCTL-1/WNV
mixture was inoculated at 3 days after RNAi silencing. The virus burden was measured at 3 (i) and 6 (ii) days after the introduction of virus by Taqman RT-QPCR.
WNV (10M.I.D50) andmosGCTL-1 (100 pg) were inoculated into eachmosquito. Each dot represents themRNA level in an individual mosquito. Statistical analysis
was done with the Mann-Whitney test. The horizontal line depicts the medians. The result shown is the combination of five independent experiments.
(D) Immunostaining of mosGCTL-1, mosPTP-1, and WNV in A. aegypti salivary glands. mosPTP-1 was stained with anti-mouse IgG Alexa-488 (green),
mosGCTL-1 was identified by anti-rabbit IgG Alexa-546 (red), and WNV E protein was probed with horse anti-E protein IgG and detected by anti-horse IgG
Alexa-633 (blue). The arrows show the sites of overlap between mosGCTL-1, mosPTP-1, and WNV at 6 days after infection. LL, lateral lobe; ML, median lobe
in female A.aegypti salivary glands. Images were examined with a Zeiss LSM 510 Meta Confocal Microscope 253 objective lens.
See also Figure S5.
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Figure 6. mosGCTL-1 Antiserum Interferes
with WNV Infection of Mosquitoes
(A) mosGCTL-1 antisera blocked the interaction
between mosGCTL-1 and WNV E protein.
mosGCTL-1 antisera or mock sera was diluted
1000-fold. The protein complex was pulled down
with a V5 mAb, and WNV E protein was detected
with an E protein antibody.
(B and C) mosGCTL-1 antisera interrupted WNV
infection during the blood meal. The antisera or
control sera were diluted 100- or 2000-fold with
fresh whole blood containing 5 3 106 pfu/ml
WNV. Membrane blood-feeding was then per-
formedwith aHemotek. Seven days later, mosqui-
toes were sacrificed to determine the infectivity
rate by Taqman RT-QPCR (B) and TCID50 (C).
Each group included 50 mosquitoes in the QPCR
assay and 32 mosquitoes in TCID50 assay. One
dot corresponds to a mosquito. n, the number of
mosquitoes in each group. The result is represen-
tative of three independent experiments.binding to mosGCTL-1, WNV binds to membrane bound
mosPTP-1. This implies that mosGCTL-1 and mosPTP-1 are
recruited as receptors to facilitate cellular invasion by WNV.
Mosquito control is a common strategy to influence
WNV numbers in nature (van der Meulen et al., 2005; Dauphin
and Zientara, 2007). The increase in viral spread and fatalities
over the last decade (Reisen and Brault, 2007; Lindsey et al.,
2009) (http://www.cdc.gov/ncidod/dvbid/westnile/index.htm)
suggests that additional strategies could assist in combating
WNV. For arthropod-bornemicrobes, vector ligands that interact
with pathogens are potential targets for interfering with
the successful acquisition of the microbe from the vertebrate
host. As an example, blocking the tick gut receptor for the
Lyme disease agent limits the colonization of ticks by Borrelia
burgdorferi (Pal et al., 2004). Our studies show that blocking
mosGCTL-1 within A. aegypti reduced the vector competence
for WNV and interrupted the infective cycle of WNV. These
results indicate that it is theoretically possible to develop a trans-
mission-blocking vaccine to interfere with the migration of WNV
from vertebrates to mosquito, thereby restricting viral dissemi-
nation in the environment.
In summary, we identified a lectin-based pathway to facilitate
flaviviral entry, in whichmosGCTL-1 andmosPTP-1 are cascade
receptors in WNV infection of A. aegypti and C. quinquefascia-
tus. Characterization of mosquito ligands for WNV enhancesCell 142, 714–725, Sour understanding of flavivirus-arthropod
interactions and may aid in the develop-
ment of strategies to target selected
points in the flaviviral life cycle and inter-
fere with these pathogens in nature.
EXPERIMENTAL PROCEDURES
Mosquitoes and Viruses
A. aegypti and C. quinquefasciatus mosquitoes
were maintained in a sugar solution at 27C and
80% humidity according to standard rearing
procedures (Keene et al., 2004; Xi et al., 2008).WNV strain 2471 and DENV-2 (DENV New Guinea C strain) were passaged
in mosquito C6/36 cells (Hanna et al., 2005; Lin et al., 2007; Krishnan et al.,
2008). The titer of WNV for cell culture was determined by a plaque formation
assay as described previously (Bai et al., 2007). The viruses for in vivo exper-
iments were titrated in mosquitoes through thoracic microinjection. The dose
of viruses was determined by 10-fold serial dilutions (i.e., 104, 105, 106, and
107) in PBS. The mosquitoes (12 in each group) were inoculated in the thorax
by microinjection with 300 nl of diluted virus. On day 6, the mosquitoes were
sacrificed, total RNA was isolated, and the viral load determined by RT-
QPCR (Figure S1). The 50% mosquito infective dose (M.I.D50) was estimated
by the Reed-Muench method (Pizzi, 1950).
Gene Silencing and Viral Challenge in Mosquitos
dsRNA synthesis was performed as described previously (Brackney et al.,
2008). The primers are shown in Table S4. For silencing the target genes, adult
female mosquitoes were kept on ice for 15 min and then transferred to a cold
tray to receive a systemic injection of dsRNA into the hemocoele. Two micro-
grams of dsRNA/300 nl in PBS was microinjected into the thorax of each
mosquito. After a 3 day recovery period, the mosquitoes were microinjected
with either WNV 10 M.I.D50/ 300 nl for functional studies or 1000 M.I.D50/
300 nl for expression profile assays.
Purification of mosGCTL-1 with the Drosophila Expression System
mosGCTL-1 was amplified by RT-PCR from adult female A. aegypti. The
primers are shown in Table S4. The PCR product was subcloned into the
pMT/BiP/V5-His A vector (Invitrogen, Carlsbad, CA) and transfected into
Drosophila S2 cells in combination with the hygromycin selection vector
pCo-Hygro for stable transfection. The cells were selected through the
use of 300 mg/ml Hygromycin-B (Invitrogen) for 4 weeks. The resistant cellseptember 3, 2010 ª2010 Elsevier Inc. 723
were grown in spinner flasks, switched to Express Five serum-free medium
(GIBCO, Invitrogen) for 3 days, and induced with copper sulfate at a final
concentration of 500 mM for 4 days. The culture medium was cleared by
centrifugation at 1000 3 g for 5 min and collected for protein purification
with the Talon metal affinity resin (Clontech, Mountain View, CA). The
protein was eluted with 150 mM imidazole, extensively dialyzed against
PBS (pH 7.8), and concentrated by centrifugal filtration through a 5 kDa
filter (Millipore, Bedford, MA). The protein purity was checked by SDS-
PAGE, and immunoblots were performed with an anti-V5-HRP mouse
mAb (Invitrogen).Isolation and Image of Mosquito Tissues
Salivary glands were dissected as the previously described (Coleman et al.,
2007). Tissues were isolated, placed on sialylated slides (PGC Scientific,
Gaithersburg, MD), washed in PBS, and fixed in 4% PFA at 37C for 1 hr.
For hemolymph isolation, the mosquitoes were anesthetized on ice tray, and
then the proboscis was removed with forceps. Hemolymph was expelled in
a droplet using the tip of the proboscis upon pressure to the thorax. Only clear
droplets were collected, to avoid contamination by the fat body (Han et al.,
1999). The liquid was allowed to be dried on sialylated slides and fixed in
4% PFA. Samples were blocked in PBS with 1% BSA and 0.1% Triton
X-100 at room temperature for 2 hr before antibody incubations. After staining
by primary and secondary antibodies, slides were imaged with the Multi-Track
mode of a Zeiss LSM 510 Meta Confocal Microscope.Membrane Blood Feeding
Fresh whole blood was obtained from C57BL/6J mice, placed in tubes with
anticoagulant, and centrifuged at 3000 rpm for 10 min to separate the serum
and cells. The serum was collected and heat inactivated at 57C for 1 hr.
The blood cells were washed in PBS three times to remove the anticoagulant.
The cells were resuspended with serum. Five million plaque forming units per
milliliter WNV and antisera (or preimmune sera) were added to the treated
blood. About 1 ml of the virus/sera/blood mixture was used on each Hemotek
feeder. The feeder was placed on the mosquito container and the mosquitoes
were allowed to feed for 1 hr. The container was transferred to 4C for 20min to
anesthetize the mosquitoes. Carefully selected fed mosquitoes were placed
into new containers and reared for 7 days. The mosquitoes were sacrificed;
the whole mosquitoes were homogenized in RLT buffer (RNeasy Mini kit,
QIAGEN) tomeasure the viral load by RT-QPCR, or grinded in PBS for virologic
assays.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and four tables and can be found with this article online at doi:10.
1016/j.cell.2010.07.038.ACKNOWLEDGMENTS
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